The global gout therapeutics market is poised for significant expansion over the next decade. Valued at USD 3.13 billion in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2034, reaching USD 6.15 billion by 2034. The increasing prevalence of gout, advancements in therapeutic options, and heightened awareness of...